cbdMD, Inc. (NYSEAMERICAN:YCBD) – Stock analysts at Cantor Fitzgerald reduced their FY2020 EPS estimates for shares of cbdMD in a research note issued on Tuesday, May 19th. Cantor Fitzgerald analyst P. Zuanic now expects that the company will earn ($0.63) per share for the year, down from their previous forecast of $0.21. Cantor Fitzgerald has a “Neutral” rating and a $1.80 price target on the stock.
cbdMD (NYSEAMERICAN:YCBD) last released its quarterly earnings data on Monday, May 18th. The company reported $0.42 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.48. The company had revenue of $9.40 million for the quarter.
Separately, Zacks Investment Research raised shares of cbdMD from a “hold” rating to a “buy” rating and set a $1.00 price objective for the company in a research note on Sunday, May 10th.
Shares of NYSEAMERICAN:YCBD opened at $1.66 on Thursday. cbdMD has a one year low of $0.50 and a one year high of $6.55.
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. AdvisorShares Investments LLC acquired a new stake in shares of cbdMD in the fourth quarter valued at about $841,000. State Street Corp grew its position in cbdMD by 6.2% during the fourth quarter. State Street Corp now owns 159,899 shares of the company’s stock worth $361,000 after buying an additional 9,381 shares in the last quarter. Oxford Asset Management LLP acquired a new stake in cbdMD during the fourth quarter worth about $50,000. Lionsbridge Wealth Management LLC acquired a new stake in cbdMD during the fourth quarter worth about $341,000. Finally, Geode Capital Management LLC grew its position in cbdMD by 9.1% during the fourth quarter. Geode Capital Management LLC now owns 158,887 shares of the company’s stock worth $359,000 after buying an additional 13,207 shares in the last quarter.
cbdMD, Inc produces and distributes various cannibidiol (CBD) products in the United States. It operates through three segments: Products, Licensing, and Entertainment. The Products segment produces and markets CBD tinctures, capsules, gummies, bath bombs, vape oils, topical creams, and animal treats and oils under the cdbMD brand.
Recommended Story: Dividend Achievers
Receive News & Ratings for cbdMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for cbdMD and related companies with MarketBeat.com's FREE daily email newsletter.